Your browser doesn't support javascript.
loading
Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis.
Fang, Yong-Sheng; Wu, Qiang; Zhao, Hong-Chuan; Zhou, Yuan; Ye, Lei; Liu, Sheng-Sheng; Li, Xiao-Xue; Du, Wei-Dong.
Afiliação
  • Fang YS; Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Wu Q; Department of Pathology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Zhao HC; Organ Transplantation Center & Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Zhou Y; Menzies Institute for Medical Research, University of Tasmania, Hobart TAS, Tasmania, Australia.
  • Ye L; Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Liu SS; Department of Pathology, Anhui Medical University, Hefei, People's Republic of China.
  • Li XX; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
  • Du WD; Department of Pathology, Anhui Medical University, Hefei, People's Republic of China.
Expert Rev Gastroenterol Hepatol ; 15(9): 1065-1076, 2021 Sep.
Article em En | MEDLINE | ID: mdl-33691550

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2021 Tipo de documento: Article